Safe and Effective Delivery of Aerosolized Medications in the Era of COVID-1 

 

Date:

October 15th @ 12 PM ET

 

Speaker:

Arzu Ari, Ph.D., RRT, PT, CPFT, FAARC, FCCP

 

Description:

During the COVID-19 pandemic there has been concern regarding staff exposure from delivering aerosolized medications to patients with the disease. This webinar will provide practical strategies on how to deliver aerosolized medications to patients with COVID-19 safely and effectively. Infection control and prevention in the era of COVID-19 will also be discussed.

 

Learning Objectives:

Upon completion of this educational activity, the participant will be able to:

  1. Describe how aerosols and droplets may be the source of respiratory pathogens.

  2. Describe practical strategies on how to deliver aerosolized medications to patients with COVID-19 safely and effectively.

  3. Discuss infection control and prevention to mitigate provider risk associated with aerosolized medications for patients with COVID-19.

 

Faculty Bio:

Dr. Arzu Ari is currently Professor Texas State University in Round Rock, TX. She is a physical therapist and a respiratory therapist by training with 24 years of experience as a manager, clinician, educator and researcher. Dr. Ari’s primary area of research is aerosol medicine. In particular, she evaluates in-vitro characterization of medical aerosols from various types of aerosol delivery systems used in the treatment of pulmonary diseases to help improve drug delivery in adult, pediatrics and infants. Her research laboratory is one of only a few in the world that can bring together the pharmaceutical, aerosol and respiratory care talent and infrastructure needed to support innovative research, build consensus and make strides in the field. Dr. Ari has published clinical practice guidelines on aerosol drug delivery and has published a range of abstracts, original research and review articles in numerous peer-reviewed journals. She has spoken on these topics at a variety of national and international medical conferences. 

Supported by an educational grant 
from

Philips Healthcare

Continuing Education for Nurses and Respiratory Therapists

This education activity is approved for 1.0 contact hour. Provider approved by California Board of Nursing, Provider # 14477  and the
Florida Board of Nursing Provider # 50-17032

This program has been approved for 1.0 Non-Traditional contact hours Continuing Respiratory Care Education (CRCE) credit by the
American Association for Respiratory Care, 9425 N. MacArthur Blvd., Suite 100, Irving TX 75063